Aziyo Stock Analysis

AZYO -  USA Stock  

USD 6.03  0.40  7.10%

The latest bullish price patterns experienced by current Aziyo Biologics shareholders could raise concerns from institutional investors as the firm it trading at a share price of 6.03 on very low momentum in volume. The company executives have been very successful in rebalancing the firm assets at opportune times to take advantage of market volatility in December. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.46. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Aziyo Biologics partners.
Please continue to Trending Equities.

Aziyo Stock Analysis 

 
Refresh
The Aziyo Biologics stock analysis report makes it easy to digest most publicly released information about Aziyo Biologics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Aziyo Stock analysis module also helps to analyze the Aziyo Biologics price relationship with some important fundamental indicators such as market cap and management efficiency.

Aziyo Stock Analysis Notes

About 115.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.1. Aziyo Biologics had not issued any dividends in recent years. Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 176 people. For more info on Aziyo Biologics please contact the company at 240 247 1147 or go to https://www.aziyo.com.

Aziyo Biologics Quarterly Cost of Revenue

7.8 MillionShare

Aziyo Biologics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aziyo Biologics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aziyo Biologics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aziyo Biologics has very high historical volatility over the last 90 days
Aziyo Biologics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 48.99 M. Net Loss for the year was (21.12 M) with profit before overhead, payroll, taxes, and interest of 20.56 M.
Aziyo Biologics currently holds about 22.54 M in cash with (14.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.2.
Aziyo Biologics has a frail financial position based on the latest SEC disclosures
Latest headline from constructionnewsportal.com: Growth Drivers of Extracellular Matrix Patches Market with Relevancy Mapping by Key Players -Koninklijke DSM NV, Smith , Nephew, Coloplast Group, Cook Group, Medtronic, Boston Scientific Cor Construction News Portal - Construction News Portal

Aziyo Biologics Upcoming and Recent Events

Earnings reports are used by Aziyo Biologics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aziyo Biologics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report7th of March 2022
Next Earnings Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End7th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Aziyo Largest EPS Surprises

Earnings surprises can significantly impact Aziyo Biologics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-03-01
2020-12-31-0.5067-0.57-0.063312 
2021-05-04
2021-03-31-0.5667-0.50.066711 
2021-11-09
2021-09-30-0.6133-0.81-0.196732 
View All Earnings Estimates

Aziyo Biologics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Aziyo Biologics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Aziyo Biologics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Aziyo Biologics specific information freely available to individual and institutional investors to make a timely investment decision.
21st of January 2022
Entry into a Material Definitive Agreement
View
7th of January 2022
Other Events. Results of Operations and Financial Condition
View
20th of December 2021
Unclassified Corporate Event
View
16th of December 2021
Unclassified Corporate Event
View
8th of December 2021
Financial Statements and Exhibits. Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
View
22nd of November 2021
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
9th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
25th of October 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View

Aziyo Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aziyo Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aziyo Biologics backward and forwards among themselves. Aziyo Biologics' institutional investor refers to the entity that pools money to purchase Aziyo Biologics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Endurant Capital Management LpCommon Shares952.6 K6.6 M
Brown Advisory IncCommon Shares230.7 K1.6 M
Perkins Capital Management IncCommon Shares228.4 K1.6 M
Platinum Investment Management LtdCommon Shares195.8 K1.4 M
Awm Investment Company IncCommon Shares126.7 K896 K
Vanguard Group IncCommon Shares55.6 K386 K
Birchview Capital LpCommon Shares50 K348 K
Note, although Aziyo Biologics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aziyo Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 76.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aziyo Biologics's market, we take the total number of its shares issued and multiply it by Aziyo Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Aziyo Profitablity

Aziyo Biologics' profitability indicators refer to fundamental financial ratios that showcase Aziyo Biologics' ability to generate income relative to its revenue or operating costs. If, let's say, Aziyo Biologics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aziyo Biologics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aziyo Biologics' profitability requires more research than a typical breakdown of Aziyo Biologics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (43.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (37.62) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.38.
Last ReportedProjected for 2022
Return on Average Assets(0.36) (0.39) 
Return on Average Equity 1.70  1.39 
Return on Invested Capital(0.33) (0.36) 
Return on Sales(0.34) (0.37) 

Management Efficiency

The entity has return on total asset (ROA) of (21.73) % which means that it has lost $21.73 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (740.82) %, meaning that it created substantial loss on money invested by shareholders. Aziyo Biologics management efficiency ratios could be used to measure how well aziyo biologics manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Average Assets is estimated to slide to -0.39. The value of Return on Average Equity is estimated to slide to 1.39. Aziyo Biologics Assets Non Current are quite stable at the moment as compared to the past year. The company's current value of Assets Non Current is estimated at 22.04 Million. Goodwill and Intangible Assets is expected to rise to about 21 M this year, although the value of Total Assets will most likely fall to about 84 M.
Last ReportedProjected for 2022
Book Value per Share 8.40  9.06 
Enterprise Value over EBIT(10.80) (11.65) 
Enterprise Value over EBITDA(13.69) (14.77) 
Price to Book Value 6.02  5.98 
Tangible Assets Book Value per Share 19.23  21.61 
Enterprise Value168.4 M167.4 M
Tangible Asset Value70.1 M56.1 M

Technical Drivers

As of the 29th of January, Aziyo Biologics shows the Risk Adjusted Performance of 0.0371, downside deviation of 5.76, and Mean Deviation of 4.47. Aziyo Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Aziyo Biologics, which can be compared to its rivals. Please confirm Aziyo Biologics semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Aziyo Biologics is priced correctly, providing market reflects its regular price of 6.03 per share. Given that Aziyo Biologics has jensen alpha of 0.2744, we suggest you to validate Aziyo Biologics's prevailing market performance to make sure the company can sustain itself at a future point.

Aziyo Biologics Price Movement Analysis

The output start index for this execution was seven with a total number of output elements of fifty-four. The Mid-point Price over period is an average of Aziyo Biologics highest and lowest prices attained during the given period. View also all equity analysis or get more info about midpoint price over period overlap studies indicator.

Aziyo Biologics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aziyo Biologics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aziyo Biologics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aziyo Biologics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aziyo Biologics Technical and Predictive Indicators

Aziyo Biologics Forecast Models

Aziyo Biologics time-series forecasting models is one of many Aziyo Biologics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aziyo Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Aziyo Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aziyo Biologics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aziyo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Aziyo Biologics. By using and applying Aziyo Stock analysis, traders can create a robust methodology for identifying Aziyo entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(0.26) (0.27) 
Gross Margin 0.55  0.55 
Profit Margin(0.53) (0.57) 
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. Aziyo Biologics, Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 176 people.

Current Aziyo Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aziyo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aziyo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
14.0Strong Buy4Odds
Aziyo Biologics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Aziyo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aziyo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aziyo Biologics, talking to its executives and customers, or listening to Aziyo conference calls.
Aziyo Analyst Advice Details

Aziyo Stock Analysis Indicators

Aziyo Biologics stock analysis indicators help investors evaluate how Aziyo Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aziyo Biologics shares will generate the highest return on investment. By understating and applying Aziyo Biologics stock analysis, traders can identify Aziyo Biologics position entry and exit signals to maximize returns.
Quick Ratio1.25
Fifty Two Week Low4.10
Revenue Growth-2.50%
Shares Short Prior Month8.13k
Average Daily Volume Last 10 Day10.2k
Average Daily Volume In Three Month16.15k
Shares Percent Shares Out0.01%
Gross Margins44.19%
Short Percent Of Float0.02%
Forward Price Earnings-2.76
Float Shares1.36M
Fifty Two Week High16.72
Enterprise Value To Ebitda-4.39
Fifty Day Average5.94
Two Hundred Day Average8.12
Enterprise Value To Revenue1.32
Please continue to Trending Equities. Note that the Aziyo Biologics information on this page should be used as a complementary analysis to other Aziyo Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Aziyo Stock analysis

When running Aziyo Biologics price analysis, check to measure Aziyo Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aziyo Biologics is operating at the current time. Most of Aziyo Biologics' value examination focuses on studying past and present price action to predict the probability of Aziyo Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aziyo Biologics' price. Additionally, you may evaluate how the addition of Aziyo Biologics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Is Aziyo Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aziyo Biologics. If investors know Aziyo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aziyo Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aziyo Biologics is measured differently than its book value, which is the value of Aziyo that is recorded on the company's balance sheet. Investors also form their own opinion of Aziyo Biologics' value that differs from its market value or its book value, called intrinsic value, which is Aziyo Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aziyo Biologics' market value can be influenced by many factors that don't directly affect Aziyo Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aziyo Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Aziyo Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aziyo Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.